The Importance of Serum Perilipin-2 Level as an Early Indicator of Inflammation in Non-Alcoholic Fatty Liver Disease
Open Access
- 28 December 2025
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 16 (1) , 106
Abstract
Background/Objectives: Non-alcoholic fatty liver disease (NAFLD), also referred to as metabolic dysfunction-associated fatty liver disease (MAFLD), is the most common chronic liver disease, closely associated with obesity and Metabolic Syndrome (MetS). Perilipin-2 (PLIN2), the most abundant lipid droplet protein in the liver, is linked to lipid accumulation and inflammation, the hallmarks of NAFLD. The role of PLIN2 in NAFLD etiopathogenesis remains partially understood. This study aims to elucidate the relationship between serum PLIN2 levels and other disease-related parameters in NAFLD, investigate the role of PLIN2 in disease pathogenesis, and evaluate its utility as a biomarker in NAFLD diagnosis. Methods: The study included 46 patients diagnosed with NAFLD who presented internal medicine outpatient clinics and 44 healthy controls. Results: Serum PLIN2 level was found to be statistically significantly higher in the NAFLD patient group compared to the control group. In the NAFLD group, a statistically significant positive correlation was detected between PLIN2 and Body Mass Index (BMI), hip circumference, C-reactive protein (CRP), and platelet count. In ROC analysis, taking the cut-off value for serum PLIN2 level as 5.52 ng/mL predicted the diagnosis of NAFLD with 50% sensitivity and 97.7% specificity. Conclusions: PLIN2 determination demonstrated high specificity at the proposed cut-off value and may represent a promising complementary biomarker for NAFLD, particularly when interpreted alongside other clinical and laboratory parameters. Circulating PLIN2 appears to be influenced by metabolic and inflammatory parameters.Keywords
This publication has 41 references indexed in Scilit:
- The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver diseaseHepatology International, 2025
- Perilipins: A family of five fat‐droplet storing proteins that play a significant role in fat homeostasisJournal of Cellular Biochemistry, 2024
- Exercise ameliorates lipid droplet metabolism disorder by the PLIN2–LIPA axis-mediated lipophagy in mouse model of non-alcoholic fatty liver diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2024
- Lifestyle and metabolic factors for nonalcoholic fatty liver disease: Mendelian randomization studyEuropean Journal of Epidemiology, 2022
- The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysisJournal of Hepatology, 2019
- Non-alcoholic fatty liver disease – A global public health perspectiveJournal of Hepatology, 2019
- New trends on obesity and NAFLD in AsiaJournal of Hepatology, 2017
- Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver diseaseJournal of Gastroenterology, 2013
- Gender-Specific Differences in Adipose Distribution and Adipocytokines Influence Adolescent Nonalcoholic Fatty Liver Disease ΔHepatology, 2010
- The metabolic syndrome—a new worldwide definitionThe Lancet, 2005